Moving on an alteration of white cells, when we must deal with a neutropenia, it is suggested to choose an anti-TNF as first-line therapy: when this is not possible, not other drugs have specific evidence to be more adequate. This evidence concerns the gene TNF and Decreased total neutrophil count.